We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New OB/GYN Products Designed for Clinical Reproductive Health Needs

By LabMedica International staff writers
Posted on 11 May 2011
A comprehensive portfolio of in vitro and in vivo products for obstetrics and gynecology (OB/GYN) patient management features both clinical laboratory diagnostic solutions and ultrasound imaging. More...
The products were designed to help physicians deal with the clinical reproductive health needs of patients.

Siemens Healthcare (Erlangen, Germany) displayed its integrated solutions for OB/GYN patient management at the 59th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG), held in Washington DC (USA) from April 30-May 4, 2011.

Highlights of Siemens OB/GYN diagnostic solutions that were unveiled at the meeting included the Immulite 1000 Immunoassay System and the latest Loci fertility assays available on Dimension Vista Intelligent lab systems. The Immulite benchtop analyzer is engineered for easy operation and reliability. It offers an extensive menu for routine and specialty immunoassay testing, including Siemens' broad range of reproductive endocrinology assays, such as estradiol, progesterone, and testosterone. Information about Siemens' full line of reproductive endocrinology platforms including the ADVIA Centaur Immunoassay Systems, Dimension integrated systems, and Immulite 2000 immunoassay system, was also available at the meeting.

Loci technology requires fewer reaction steps resulting in fast turnaround times. The Loci assays include luteinizing hormone (LH), follicle-stimulating hormone (FSH), and prolactin. LH and FSH are useful in the clinical evaluation of gonadal and pituitary disorders, while prolactin is used in the diagnosis and treatment of disorders of the anterior pituitary gland and hypothalamus portion of the brain.

Several of Siemens' ultrasound imaging solutions for OB/GYN care were also introduced at the meeting.

Related Links:
Siemens Healthcare



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.